PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28781340-7	2018	RESULTS: Both K-877 and fenofibrate suppressed body weight gain and fasting and postprandial TG levels and enhanced LPL activity in mice fed an HFD.	Fenofibrate	24-35	lipoprotein lipase	Mus musculus	116-119	
16477380-9	2006	These results demonstrate that fenofibrate improves lipid abnormalities partly via inhibition of TG production and partly via clearance of TG-rich apoB particles by elevating LPL and reduced apoCIII.	Fenofibrate	31-42	lipoprotein lipase	Mus musculus	175-178	
28941594-7	2017	Additionally, elevated MIF levels in serum from LPL+/- mice and PA-treated MIN6 cells were starkly decreased after Fenofibrate administration.	Fenofibrate	115-126	lipoprotein lipase	Mus musculus	48-51	
20501652-9	2010	We conclude that fenofibrate decreases plasma TG by enhancing LPL-mediated VLDL-TG clearance, which results in a compensatory increase in VLDL-TG production by the liver.	Fenofibrate	17-28	lipoprotein lipase	Mus musculus	62-65	
16226489-9	2005	Further, fenofibrate-treated mice presented decreased in vivo [3H]VLDL catabolism and decreased VLDL-triglyceride hydrolysis by exogenous LPL.	Fenofibrate	9-20	lipoprotein lipase	Mus musculus	138-141